Business
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y., September 30, 2025--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
About this update from Siemens Healthineers Ag
[{"type":"image","alt":"The Atellica DT 250 Analyzer from Siemens Healthineers makes quality drug testing easier to perform. It helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing. It also offers automated specimen validity testing to detect substitution, adulteration, and dilution of urine samples to flag suspicious samples early. The Atellica DT 250 Analyzer streamlines drug testing capabilities previously limited to larger, floor-standing models onto one benchtop analyzer and can process 225 test results per hour, with first results provided in as soon as eight minutes.","displaySize":"","headline":null,"caption":"The Atellica DT 250 Analyzer from Siemens Healthineers makes quality drug testing easier to perform. It helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing. It also offers automated specimen validity testing to detect substitution, adulteration, and dilution of urine samples to flag suspicious samples early. The Atellica DT 250 Analyzer streamlines drug testing capabilities previously limited to larger, floor-standing models onto one benchtop analyzer and can process 225 test results per hour, with first results provided in as soon as eight minutes.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/0f7eebcaeaa4b19d0067fdc2f405a8a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/A7032mDe48.kdGX_TNZu9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0f7eebcaeaa4b19d0067fdc2f405a8a7","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2780,"height":652,"url":"https://media.zenfs.com/en/business-wire.com/c5a3e462f33d560eb60a6f51375fc5a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7N6C.SPrsnsfpJ7uyr8gAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIyNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c5a3e462f33d560eb60a6f51375fc5a7","width":960,"height":225},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/70zVut6VGxQSyiOcxsouCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01NjI7Y2Y9d2VicA--/https://media.zenfs.com/en/bu...